Cargando…
The Coming Age of Flavonoids in the Treatment of Diabetic Complications
Diabetes mellitus (DM), and its micro and macrovascular complications, is one of the biggest challenges for world public health. Despite overall improvement in prevention, diagnosis and treatment, its incidence is expected to continue increasing over the next years. Nowadays, finding therapies to pr...
Autores principales: | Caro-Ordieres, Teresa, Marín-Royo, Gema, Opazo-Ríos, Lucas, Jiménez-Castilla, Luna, Moreno, Juan Antonio, Gómez-Guerrero, Carmen, Egido, Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074336/ https://www.ncbi.nlm.nih.gov/pubmed/32012726 http://dx.doi.org/10.3390/jcm9020346 |
Ejemplares similares
-
Nephroprotective Effects of Synthetic Flavonoid Hidrosmin in Experimental Diabetic Nephropathy
por: Jiménez-Castilla, Luna, et al.
Publicado: (2021) -
The Synthetic Flavonoid Hidrosmin Improves Endothelial Dysfunction and Atherosclerotic Lesions in Diabetic Mice
por: Jiménez-Castilla, Luna, et al.
Publicado: (2022) -
Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities
por: Opazo-Ríos, Lucas, et al.
Publicado: (2020) -
Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy
por: Opazo-Ríos, Lucas, et al.
Publicado: (2020) -
Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice
por: Opazo-Ríos, Lucas, et al.
Publicado: (2022)